The value of the single-cell analysis market will advance at a rate of 11.6% by the end of this decade, to reach USD 10,304.3 million by 2030. The industry growth has a lot to do with the pace of tech progressions and increasing cancer prevalence. Among numerous applications, like stem cell, oncology, neurology, immunology, non-invasive prenatal diagnosis, and IVF. Oncology … Continua a leggere→